145 related articles for article (PubMed ID: 31739707)
1. Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis.
Reid JH; Perissinotti AJ; Benitez L; Bixby DL; Burke P; Pettit K; Marini BL
Leuk Lymphoma; 2020 Apr; 61(4):862-868. PubMed ID: 31739707
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
[TBL] [Abstract][Full Text] [Related]
3. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
Cortes J; O'Brien SM; Pierce S; Keating MJ; Freireich EJ; Kantarjian HM
Blood; 1995 Sep; 86(6):2091-7. PubMed ID: 7662956
[TBL] [Abstract][Full Text] [Related]
4. Central Nervous System Prophylaxis and Treatment in Acute Leukemias.
Wu SY; Short NJ; Nasr L; Dabaja BS; Fang PQ
Curr Treat Options Oncol; 2022 Dec; 23(12):1829-1844. PubMed ID: 36510037
[TBL] [Abstract][Full Text] [Related]
5. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
6. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
Sancho JM; Morgades M; Arranz R; Fernández-Abellán P; Deben G; Alonso N; Blanes M; Rodríguez MJ; Nicolás C; Sánchez E; Fernández de Sevilla A; Conde E; Ribera JM;
Med Clin (Barc); 2008 Oct; 131(11):401-5. PubMed ID: 18928719
[TBL] [Abstract][Full Text] [Related]
7. Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change.
Lee BJ; Kongtim P; Doh J; Griffin SP; Chan A; O'Brien S; Ciurea SO; Jeyakumar D
Eur J Haematol; 2023 Jul; 111(1):154-160. PubMed ID: 37086155
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system involvement at first relapse in patients with acute myeloid leukemia.
Martínez-Cuadrón D; Montesinos P; Pérez-Sirvent M; Avaria A; Cordón L; Rodríguez-Veiga R; Martín G; Sanz J; Martínez J; Sanz MA
Haematologica; 2011 Sep; 96(9):1375-9. PubMed ID: 21565904
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System.
Hall KH; Valla K; Flowers CR; Cohen JB
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):89-94. PubMed ID: 30528416
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
11. Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.
Zheng C; Liu X; Zhu W; Cai X; Wu J; Sun Z
Hematology; 2014 Jun; 19(4):208-12. PubMed ID: 24074528
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
Belasco JB; Goldwein JW; Simms S; Griffin G; D'Angio G; Lange B
Med Pediatr Oncol; 2000 Feb; 34(2):125-31. PubMed ID: 10657874
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement.
Sastow D; Tatarian J; Riazat-Kesh YJRA; Farina K; Becker M; Feld J; Kremyanskaya M; Mascarenhas J; Byrd K; Male HJ; Lin TL; Tremblay D
Leuk Lymphoma; 2023 Dec; 64(12):2002-2007. PubMed ID: 37590099
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
[TBL] [Abstract][Full Text] [Related]
16. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
Rozovski U; Ohanian M; Ravandi F; Garcia-Manero G; Faderl S; Pierce S; Cortes J; Estrov Z
Leuk Lymphoma; 2015 May; 56(5):1392-7. PubMed ID: 25110819
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system relapse in adults with acute lymphoblastic leukemia.
Surapaneni UR; Cortes JE; Thomas D; O'Brien S; Giles FJ; Koller C; Faderl S; Kantarjian H
Cancer; 2002 Feb; 94(3):773-9. PubMed ID: 11857312
[TBL] [Abstract][Full Text] [Related]
19. Successful Treatment of Relapsed Pediatric Acute Myeloid Leukemia Presenting as Central Nervous System Myeloid Sarcoma: A Single-Institution Case Series.
Bujold KE; Dandekar S; Barbour M
J Pediatr Hematol Oncol; 2020 May; 42(4):319-321. PubMed ID: 30543582
[TBL] [Abstract][Full Text] [Related]
20. Isolated central nervous system relapse in childhood acute promyelocytic leukemia.
Scheinemann K; Weitzman S; Hitzler J; Doyle J; Abla O
J Pediatr Hematol Oncol; 2008 Feb; 30(2):160-2. PubMed ID: 18376270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
